je.st
news
Tag: eli lilly
Eli Lilly 2015 forecast falls short of Street expectations
2015-01-07 18:13:31| Biotech - Topix.net
The maker of the antidepressant Cymbalta said it expects adjusted earnings to range between $3.10 and $3.20 per share on between $20.3 billion and $20.8 billion in revenue in the new year, as it continues to recover from the loss of patents protecting several key products from cheaper generic drugs. That would represent as much as 17 percent growth from its forecast for 2014 earnings of between $2.72 and $2.80 per share.
Tags: short
street
falls
expectations
Eli Lilly: The Blockbuster Combination Of Elanco And Novartis' Animal Health
2015-01-03 11:18:31| Biotech - Topix.net
Elanco has been recently authorized by the FTC to take over Novartis' Animal Health segment, along with a condition to sell off Novartis' Sentinel product line. This combination will raise Eli Lilly's global market rank to number 2 in the animal pharmaceutical market in terms of total revenue, following Zoetis, which has topped the list.
Tags: health
combination
animal
eli
Eli Lilly and Given Average Recommendation of "Buy" by Brokerages
2014-12-16 21:07:29| Agriculture - Topix.net
Eli Lilly and has earned an average rating of "Buy" from the twenty ratings firms that are currently covering the company, American Banking News reports . Six equities research analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company.
Tags: buy
average
recommendation
eli
Eli Lilly and Sets New 12-Month High at $75.10
2014-12-12 03:39:41| Agriculture - Topix.net
Eli Lilly and 's share price hit a new 52-week high on Thursday , AmericanBankingNews.com reports. The stock traded as high as $75.10 and last traded at $73.44, with a volume of 4,958,207 shares trading hands.
What Eli Lilly Can Do To Keep Its Amazing Rally Going In 2015
2014-12-06 11:24:05| Agriculture - Topix.net
However, Eli Lilly's dividend has not grown in this time, which is surely disappointing to income investors. This is despite Eli Lilly's strong fundamentals, which support an increase.
Sites : [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] next »